ZTE Corporation, a major international provider of telecommunications, enterprise and consumer technology solutions for the Mobile Internet, is pleased to become the first company to complete tests set up by Dept. of Big Data and IT Technology, China Mobile Research Institute for Internet of Things (IOT) docking and interoperability, a key step in the deployment of cloud-based Network Function Virtualization (NFV） technologies.
During the NFV test, ZTE adopted management and orchestration (MANO) and IMS solutions, which fully satisfied China Mobile’s requirements in tests for a comprehensive range of IOT network virtualization functions including NE template management, fast and automatic service deployment, hot VM migration, failure recovery, dynamic Scale in and Scale Out. ZTE worked together with many partners including VMware, Hewlett-Packard and Redhat in a multi-vendor test environment designed to verify the interoperability of different configurations of hardware resource layers, virtual resource layers and virtualized network functions (VNF) layers.
During the test, ZTE’s solutions scored high ratings from China Mobile for their performance and the ability to support fast and automatic service deployment, as well as simplicity and usability.
ZTE’s industry-leading MANO solutions support flexible orchestration of physical resources, virtual resources, VNF and network services, providing end-to-end integrated management and O&M of NFVI, VIM and VNF layers to help customers shorten service time-to-market and reduce operating expenses. The openness and compatibility of ZTE’s NFV technologies also help promote and accelerate commercialization and large-scale deployment by operators.
ZTE is committed to playing a leading role in the development of network virtualization technologies globally, building strategic partnerships with other technology providers on testing and verification to accelerate industry deployment. To date, ZTE’s virtualized core network solutions including Cloud UniCore are deployed in 12 commercial and 32 trial projects globally.